References
- Gatter K C, Warnke R A. Intravascular large B cell lymphoma. World Health Organization: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissue, E S Jaffe, N L Harris, H Stein, J Vardiman. IARC Press, Lyon 2001; 177–178
- Ferreri A J, Campo E, Seymour J F, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 2004; 127: 173–183
- Khalidi H S, Brynes R K, Browne P, Koo C H, Battifora H, Medeiros L J. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. Mod Pathol 1998; 11: 983–988
- Ferreri A J, Campo E, Ambrosetti A, Ilariucci F, Seymour J F, Willemze R, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncology 2004; 15: 1215–1221
- Coiffier B, Lepage E, Brière J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242
- Jang H J, Lee K S, Han J. Intravascular lymphomatosis of the lung: radiologic findings. J Comput Assist Tomogr 1998; 22: 427–429
- Ponzoni M, Arrigoni G, Gould V E, Del Curto B, Maggioni M, Scapinello A, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000; 31: 220–226
- Rose C, Staumont D, Jouet J P. Successful autologous bone marrow transplantation in intravascular lymphomatosis. Br J Haematol 1999; 105: 313–314
- Sawamoto A, Narimatsu H, Suzuki T, Kurahashi S, Sugimoto T, Sugiura I. Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma. Bone Marrow Transplant 2006; 37: 233–234
- Davis T S. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan. Leuk Lymphoma 2003; 44: 887–888
- Weichert G, Martinka M, Rivers J K. Intravascular lymphoma presenting as telangectasias: response to rituximab and combination chemotherapy. J Cutan Med Surg 2003; 7: 460–463
- Jardin F, Callonnec F, Contentin N, Picquenot J M, Gueit I, Heron F, et al. Intravascular large B-cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen. Clin Lymphoma 2005; 6: 46–49
- Takacs I, Eros N, Bene I, Bozso F, Tordai L, Karolyi Z, et al. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy. Ann Hematol 2004; 83: 608–610
- Bazhenova L, Higginbottom P, Mason J. Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma 2006; 47: 337–341
- Maloney D G, Smith B, Rose A. Rituximab: mechanism of action and resistance. Semin Oncol 2002; 29(Suppl 2)2–9
- Jabr M I. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma. Int J Hematol 2005; 82: 312–314